Relevance of tumor models for anticancer drug development:
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Basel
Karger
1999
|
| Series: | Contributions to Oncology
Vol. 54 |
| Subjects: | |
| Online Access: | Volltext |
| Physical Description: | 1 Online-Ressource (461 Seiten) Illustrationen |
| ISBN: | 9783318034370 9783805567862 3805567863 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV043460374 | ||
| 003 | DE-604 | ||
| 005 | 20210928 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160315s1999 xx a||| o|||| 10||| eng d | ||
| 020 | |a 9783318034370 |c Online |9 978-3-318-03437-0 | ||
| 020 | |a 9783805567862 |c Print |9 978-3-8055-6786-2 | ||
| 020 | |a 3805567863 |c Print |9 3-8055-6786-3 | ||
| 035 | |a (OCoLC)951904104 | ||
| 035 | |a (DE-599)BVBBV043460374 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-384 |a DE-703 |a DE-29 |a DE-19 |a DE-91 |a DE-739 |a DE-355 |a DE-521 |a DE-11 |a DE-83 |a DE-473 |a DE-20 |a DE-1028 |a DE-573 |a DE-859 |a DE-M347 |a DE-1049 |a DE-92 |a DE-898 |a DE-863 |a DE-862 |a DE-522 |a DE-526 |a DE-1102 |a DE-54 |a DE-128 |a DE-22 |a DE-70 |a DE-150 |a DE-155 |a DE-M382 |a DE-1046 | ||
| 050 | 0 | |a RM301.25 | |
| 084 | |a XI 7005 |0 (DE-625)153024:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Relevance of tumor models for anticancer drug development |c volume editors H.H. Fiebig, A.M. Burger |
| 264 | 1 | |a Basel |b Karger |c 1999 | |
| 300 | |a 1 Online-Ressource (461 Seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 1 | |a Contributions to Oncology |v Vol. 54 | |
| 650 | 4 | |a Antineoplastic Agents |x therapeutic use |v Congresses | |
| 650 | 4 | |a Antineoplastic agents x̲ Testing |v Congresses | |
| 650 | 4 | |a Cancer x̲ Chemotherapy x̲ Evaluation |v Congresses | |
| 650 | 4 | |a Disease Models, Animal |v Congresses | |
| 650 | 4 | |a Drug Evaluation, Preclinical |v Congresses | |
| 650 | 4 | |a Tumors |x Animal models | |
| 650 | 0 | 7 | |a Tiermodell |0 (DE-588)4140660-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tumor |0 (DE-588)4078460-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a In vitro |0 (DE-588)4250701-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Modell |0 (DE-588)4039798-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1997 |z Freiburg, Breisgau |2 gnd-content | |
| 689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | 2 | |a Tumor |0 (DE-588)4078460-5 |D s |
| 689 | 0 | 3 | |a Modell |0 (DE-588)4039798-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | 2 | |a Tiermodell |0 (DE-588)4140660-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 2 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 2 | 2 | |a In vitro |0 (DE-588)4250701-7 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Fiebig, Heinz H. |4 edt | |
| 830 | 0 | |a Contributions to Oncology |v Vol. 54 |w (DE-604)BV040622225 |9 54 | |
| 856 | 4 | 0 | |u http://www.karger.com/Book/Home/223502 |x Verlag |3 Volltext |
| 912 | |a ZDB-1-KEC | ||
| 912 | |a ZDB-1-KEB | ||
| 940 | 1 | |q ZDB-1-KEC16 | |
| 940 | 1 | |q ZDB-1-KEB16 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-028877584 | |
Record in the Search Index
| DE-BY-FWS_katkey | 613730 |
|---|---|
| _version_ | 1824554508403867648 |
| adam_text | |
| any_adam_object | |
| author2 | Fiebig, Heinz H. |
| author2_role | edt |
| author2_variant | h h f hh hhf |
| author_facet | Fiebig, Heinz H. |
| building | Verbundindex |
| bvnumber | BV043460374 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.25 |
| callnumber-search | RM301.25 |
| callnumber-sort | RM 3301.25 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | XI 7005 |
| collection | ZDB-1-KEC ZDB-1-KEB |
| ctrlnum | (OCoLC)951904104 (DE-599)BVBBV043460374 |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV043460374</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210928</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160315s1999 xx a||| o|||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783318034370</subfield><subfield code="c">Online</subfield><subfield code="9">978-3-318-03437-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783805567862</subfield><subfield code="c">Print</subfield><subfield code="9">978-3-8055-6786-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805567863</subfield><subfield code="c">Print</subfield><subfield code="9">3-8055-6786-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)951904104</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043460374</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-83</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-1028</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-859</subfield><subfield code="a">DE-M347</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-863</subfield><subfield code="a">DE-862</subfield><subfield code="a">DE-522</subfield><subfield code="a">DE-526</subfield><subfield code="a">DE-1102</subfield><subfield code="a">DE-54</subfield><subfield code="a">DE-128</subfield><subfield code="a">DE-22</subfield><subfield code="a">DE-70</subfield><subfield code="a">DE-150</subfield><subfield code="a">DE-155</subfield><subfield code="a">DE-M382</subfield><subfield code="a">DE-1046</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.25</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7005</subfield><subfield code="0">(DE-625)153024:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Relevance of tumor models for anticancer drug development</subfield><subfield code="c">volume editors H.H. Fiebig, A.M. Burger</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">Karger</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (461 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Contributions to Oncology</subfield><subfield code="v">Vol. 54</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents x̲ Testing</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer x̲ Chemotherapy x̲ Evaluation</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Disease Models, Animal</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumors</subfield><subfield code="x">Animal models</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tiermodell</subfield><subfield code="0">(DE-588)4140660-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">In vitro</subfield><subfield code="0">(DE-588)4250701-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Modell</subfield><subfield code="0">(DE-588)4039798-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1997</subfield><subfield code="z">Freiburg, Breisgau</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Modell</subfield><subfield code="0">(DE-588)4039798-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Tiermodell</subfield><subfield code="0">(DE-588)4140660-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">In vitro</subfield><subfield code="0">(DE-588)4250701-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fiebig, Heinz H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Contributions to Oncology</subfield><subfield code="v">Vol. 54</subfield><subfield code="w">(DE-604)BV040622225</subfield><subfield code="9">54</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.karger.com/Book/Home/223502</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-KEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-KEB</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-1-KEC16</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-1-KEB16</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028877584</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1997 Freiburg, Breisgau gnd-content |
| genre_facet | Konferenzschrift 1997 Freiburg, Breisgau |
| id | DE-604.BV043460374 |
| illustrated | Illustrated |
| indexdate | 2025-02-20T06:52:53Z |
| institution | BVB |
| isbn | 9783318034370 9783805567862 3805567863 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028877584 |
| oclc_num | 951904104 |
| open_access_boolean | |
| owner | DE-12 DE-384 DE-703 DE-29 DE-19 DE-BY-UBM DE-91 DE-BY-TUM DE-739 DE-355 DE-BY-UBR DE-521 DE-11 DE-83 DE-473 DE-BY-UBG DE-20 DE-1028 DE-573 DE-859 DE-M347 DE-1049 DE-92 DE-898 DE-BY-UBR DE-863 DE-BY-FWS DE-862 DE-BY-FWS DE-522 DE-526 DE-1102 DE-54 DE-128 DE-22 DE-BY-UBG DE-70 DE-150 DE-155 DE-BY-UBR DE-M382 DE-1046 |
| owner_facet | DE-12 DE-384 DE-703 DE-29 DE-19 DE-BY-UBM DE-91 DE-BY-TUM DE-739 DE-355 DE-BY-UBR DE-521 DE-11 DE-83 DE-473 DE-BY-UBG DE-20 DE-1028 DE-573 DE-859 DE-M347 DE-1049 DE-92 DE-898 DE-BY-UBR DE-863 DE-BY-FWS DE-862 DE-BY-FWS DE-522 DE-526 DE-1102 DE-54 DE-128 DE-22 DE-BY-UBG DE-70 DE-150 DE-155 DE-BY-UBR DE-M382 DE-1046 |
| physical | 1 Online-Ressource (461 Seiten) Illustrationen |
| psigel | ZDB-1-KEC ZDB-1-KEB ZDB-1-KEC16 ZDB-1-KEB16 |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Karger |
| record_format | marc |
| series | Contributions to Oncology |
| series2 | Contributions to Oncology |
| spellingShingle | Relevance of tumor models for anticancer drug development Contributions to Oncology Antineoplastic Agents therapeutic use Congresses Antineoplastic agents x̲ Testing Congresses Cancer x̲ Chemotherapy x̲ Evaluation Congresses Disease Models, Animal Congresses Drug Evaluation, Preclinical Congresses Tumors Animal models Tiermodell (DE-588)4140660-6 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd Tumor (DE-588)4078460-5 gnd In vitro (DE-588)4250701-7 gnd Modell (DE-588)4039798-1 gnd |
| subject_GND | (DE-588)4140660-6 (DE-588)4143176-5 (DE-588)4068347-3 (DE-588)4078460-5 (DE-588)4250701-7 (DE-588)4039798-1 (DE-588)1071861417 |
| title | Relevance of tumor models for anticancer drug development |
| title_auth | Relevance of tumor models for anticancer drug development |
| title_exact_search | Relevance of tumor models for anticancer drug development |
| title_full | Relevance of tumor models for anticancer drug development volume editors H.H. Fiebig, A.M. Burger |
| title_fullStr | Relevance of tumor models for anticancer drug development volume editors H.H. Fiebig, A.M. Burger |
| title_full_unstemmed | Relevance of tumor models for anticancer drug development volume editors H.H. Fiebig, A.M. Burger |
| title_short | Relevance of tumor models for anticancer drug development |
| title_sort | relevance of tumor models for anticancer drug development |
| topic | Antineoplastic Agents therapeutic use Congresses Antineoplastic agents x̲ Testing Congresses Cancer x̲ Chemotherapy x̲ Evaluation Congresses Disease Models, Animal Congresses Drug Evaluation, Preclinical Congresses Tumors Animal models Tiermodell (DE-588)4140660-6 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd Tumor (DE-588)4078460-5 gnd In vitro (DE-588)4250701-7 gnd Modell (DE-588)4039798-1 gnd |
| topic_facet | Antineoplastic Agents therapeutic use Congresses Antineoplastic agents x̲ Testing Congresses Cancer x̲ Chemotherapy x̲ Evaluation Congresses Disease Models, Animal Congresses Drug Evaluation, Preclinical Congresses Tumors Animal models Tiermodell Arzneimittelentwicklung Cytostatikum Tumor In vitro Modell Konferenzschrift 1997 Freiburg, Breisgau |
| url | http://www.karger.com/Book/Home/223502 |
| volume_link | (DE-604)BV040622225 |
| work_keys_str_mv | AT fiebigheinzh relevanceoftumormodelsforanticancerdrugdevelopment |